| Autor: |
Oosting M; Department of Internal Medicine., Cheng SC; Department of Internal Medicine., Bolscher JM; Department of Immune Therapeutics, Merck Research Laboratories, Oss 5342 CC, The Netherlands., Vestering-Stenger R; Department of Internal Medicine., Plantinga TS; Department of Internal Medicine., Verschueren IC; Department of Internal Medicine., Arts P; Department of Human Genetics., Garritsen A; Department of Immune Therapeutics, Merck Research Laboratories, Oss 5342 CC, The Netherlands., van Eenennaam H; Department of Immune Therapeutics, Merck Research Laboratories, Oss 5342 CC, The Netherlands., Sturm P; Department of Microbiology, and., Kullberg BJ; Department of Internal Medicine., Hoischen A; Department of Human Genetics., Adema GJ; Department of Tumour Immunology, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands; and., van der Meer JW; Department of Internal Medicine., Netea MG; Department of Internal Medicine., Joosten LA; Department of Internal Medicine, leo.joosten@radboudumc.nl. |
| Jazyk: |
angličtina |
| Zdroj: |
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2014 Oct 21; Vol. 111 (42), pp. E4478-84. Date of Electronic Publication: 2014 Oct 06. |
| DOI: |
10.1073/pnas.1410293111 |
| Abstrakt: |
Toll-like receptor (TLR)10 is the only pattern-recognition receptor without known ligand specificity and biological function. We demonstrate that TLR10 is a modulatory receptor with mainly inhibitory effects. Blocking TLR10 by antagonistic antibodies enhanced proinflammatory cytokine production, including IL-1β, specifically after exposure to TLR2 ligands. Blocking TLR10 after stimulation of peripheral blood mononuclear cells with pam3CSK4 (Pam3Cys) led to production of 2,065 ± 106 pg/mL IL-1β (mean ± SEM) in comparison with 1,043 ± 51 pg/mL IL-1β after addition of nonspecific IgG antibodies. Several mechanisms mediate the modulatory effects of TLR10: on the one hand, cotransfection in human cell lines showed that TLR10 acts as an inhibitory receptor when forming heterodimers with TLR2; on the other hand, cross-linking experiments showed specific induction of the anti-inflammatory cytokine IL-1 receptor antagonist (IL-1Ra, 16 ± 1.7 ng/mL, mean ± SEM). After cross-linking anti-TLR10 antibody, no production of IL-1β and other proinflammatory cytokines could be found. Furthermore, individuals bearing TLR10 polymorphisms displayed an increased capacity to produce IL-1β, TNF-α, and IL-6 upon ligation of TLR2, in a gene-dose-dependent manner. The modulatory effects of TLR10 are complex, involving at least several mechanisms: there is competition for ligands or for the formation of heterodimer receptors with TLR2, as well as PI3K/Akt-mediated induction of the anti-inflammatory cytokine IL-1Ra. Finally, transgenic mice expressing human TLR10 produced fewer cytokines when challenged with a TLR2 agonist. In conclusion, to our knowledge we demonstrate for the first time that TLR10 is a modulatory pattern-recognition receptor with mainly inhibitory properties. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
